MedicarePartD.guide

A non-government resource built from CMS public data

Ryaltris on HealthSpring Assurance Rx (S5617-218)

olopatadine hydrochloride and mometasone furoate

Covered, with step therapy.

Tier 4 (non-preferred drug). No quantity limit.

31%
Patient pays / month, after deductible
31%
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

RYALTRIS 665/25 ug Spray, Metered at a preferred retail pharmacy.

Prior authNot required· Step therapy applies· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)

Verify with the plan before prescribing or filling. Member services: (800)222-6700. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5617-218